Judge Pauses Invalidation Of Patent For Janssen's Zytiga
A New Jersey federal judge on Tuesday paused his Friday order that invalidated a patent covering Janssen Biotech Inc.'s blockbuster oncology medication Zytiga, allowing the company to appeal the opinion to...To view the full article, register now.
Already a subscriber? Click here to view full article